Thursday, May 10, 2007

Schering Plough - Intron A/Temador: nose thumbing fine




U.S. District Judge Patti Saris had seen cases such as this before, and she was fed up.

Another pharmaceutical company was in her court, waiting to be slapped with a multimillion-dollar fine for marketing its drugs for uses that the federal Food & Drug Administration had not approved.

"You can't thumb your nose at the FDA," Saris said.

She sentenced Schering Sales Corp. and its parent company, Schering-Plough Corp., earlier this year to pay $435 million to settle allegations that it lied to the government about drug prices and illegally promoted the drugs Temodar and Intron A for the treatment of cancers for which they were not approved.

More

No comments: